Credit: ARS Pharmaceuticals. Neffy 1mg is expected to be available by the end of May 2025. For patients weighing 15kg to less than 30kg, the recommended dose is 1 spray of neffy 1mg. The Food and Drug ...

ARS Pharmaceuticals has announced the availability of neffy (epinephrine nasal spray) 1mg in the US, providing a new option for treating Type I allergic reactions, including anaphylaxis, in children ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, an operating company of Fresenius, announced today that Epinephrine Injection, USP, is now available in the United States as the first generic ...

The availability of neffy 1 mg extends protection to younger, school-aged children—who make up nearly 23% of people needing epinephrine Visit neffy.com for savings and support programs and pay as ...

Credit: ARS Pharmaceuticals. Each carton contains 2 blister packages each with a single-dose nasal spray product for 1 time use. It is recommended that patients be prescribed and have immediate access ...

neffy 1 mg is the first approved needle-free epinephrine nasal spray for children aged 4 to 30 kg, addressing severe allergic reactions. ARS Pharmaceuticals announced the FDA approval of neffy 1 mg, ...

The US Food and Drug Administration (FDA) has approved ARS Pharmaceuticals' neffy 1mg (epinephrine nasal spray) for treating type one allergic reactions including anaphylaxis in paediatric patients ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Fear of needles may delay treatment with injectable ...

(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) announced that the U.S. FDA has approved its Epinephrine injection USP, 1 mg/mL, in both single-dose and multi-dose for use in U.S. hospitals.

First generic version of Epinephrine 1mg/1mL vial in U.S. market LAKE ZURICH, Ill., December 17, 2024--(BUSINESS WIRE)--Fresenius Kabi, an operating company of Fresenius, announced today that ...